Telos Reports Strong Q1 2026 Results, Returns to Profitability, and Expands Share Repurchase Program

summarizeSummary

Telos Corporation reported strong Q1 2026 financial results, including a return to net income and significant revenue growth, alongside a substantial expansion of its share repurchase program.

check_boxKey Events

• Strong Q1 2026 Financial Performance

  Revenue increased 55.9% year-over-year to $47.7 million, and the company shifted from a net loss of $8.6 million in Q1 2025 to a net income of $2.0 million in Q1 2026. Operating cash flow also improved significantly to $8.7 million.

• Share Repurchase Program Expanded

  The Board authorized an additional $25.0 million for the existing share repurchase program on March 12, 2026, bringing the total remaining authorization to approximately $47.9 million. The company repurchased 517,136 shares for $2.2 million during the quarter.

• CEO Takes Medical Leave

  President, CEO, and Chairman John Wood began a medical leave of absence on April 29, 2026. An interim leadership team has been appointed, and the company does not anticipate material operational disruption.

• Equity Incentive Plan Increase Approved

  Stockholders approved an amendment to the 2016 Long-Term Incentive Plan on May 7, 2026, increasing the shares available for issuance by 5,380,000.

auto_awesomeAnalysis

Telos Corporation reported robust first-quarter 2026 financial results, marking a significant turnaround with a return to profitability and substantial revenue growth. The company also announced a material expansion of its share repurchase program, authorizing an additional $25 million, which demonstrates a strong commitment to shareholder returns. While the CEO's medical leave and the equity incentive plan increase were previously disclosed, this 10-Q provides the full financial details and new information on the expanded repurchase authorization and a new factoring agreement to enhance liquidity.